Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2025 11:00 ET | Source: Quantum Leap Healthcare Collaborative

Quantum Leap Healthcare Collaborative Welcomes Three Esteemed Leaders to Its Board of Directors

San Francisco, CA, April 28, 2025 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC) is proud to announce the appointment of three distinguished leaders to its Board of Directors: Dr....
March 19, 2025 07:00 ET | Source: Quantum Leap Healthcare Collaborative

Evinova and Quantum Leap Healthcare Partner to Incorporate Real-Time Remote Patient Monitoring into Breast Cancer Platform Trial

San Francisco, CA, March 19, 2025 (GLOBE NEWSWIRE) -- Evinova, a global clinical trial technology company with proven published outcomes for sponsors, sites and patients, announced today an...
December 09, 2024 11:00 ET | Source: Quantum Leap Healthcare Collaborative

Quantum Leap Healthcare Collaborative Announces Completion of Datopotamab Deruxtecan and Datopotamab Deruxtecan + Durvalumab Arms in the I-SPY2 Trial for Stage 2/3 Neoadjuvant Breast Cancer

San Francisco, CA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor and operator of the I-SPY 2 Trial, announces the completion of enrollment for two arms...
September 16, 2024 09:00 ET | Source: Quantum Leap Healthcare Collaborative

Second generation of I-SPY 2 TRIAL design is driving the “precise” in precision medicine

Washington D.C, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative™ (QLHC), a non-profit organization and sponsor of the I-SPY 2.2 TRIAL™, presented an overview of the...
August 21, 2024 11:30 ET | Source: Quantum Leap Healthcare Collaborative

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer

Seattle, WA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SEATTLE, August 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare...